You can read the full September 18th print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
The U.S. Department of Labor reported hospitals in 2022 endured 22% staff turnover rates, hindering efforts to implement individualized patient care plans. As the health care industry seeks resources to rebound and elevate patient care, industry experts have cited patient medication nonadherence as a major roadblock taxing the health care industry’s efforts to individualize care
Think about last flu season. Odds are that pharmacy customers experienced longer waits, staff saw greater backlogs and increased burnout all while admirably dealing with a surge of vaccinations on top of dispensing, counseling and clinical responsibilities. To further complicate staffing challenges, those who were allowed to hire additional staff struggled to find applicants. This
The abrupt end of the Roz Brewer era at Walgreens Boots Alliance and appointment of Ginger Graham as interim chief executive officer serves as a lens for bringing into focus the current state of the company, the urgent challenges that need to be addressed, and the expanded role that WBA envisions for itself in health
The stunning announcement out of Chicago earlier this month to the effect that Walgreens and its chief executive, Roz Brewer, would be parting ways shocked the chain drug community as few personnel changes have done in many a day. Among the questions and observations randomly tossed around, one hung relentlessly above the rest: Why? Why,
When a patient needs a medication for a minor ailment, what’s their first step? Usually, the process is anything but user-friendly. Just getting a prescription for pink eye might involve multiple touchpoints across several locations—scheduling through a doctor’s office, seeing a physician, and finally speaking to a pharmacist after obtaining a script. The experience is
